in high-risk gestational choriocarcinoma patients , a weekly schedule of chemotherapy , alternating ema ( vp-16 , methotrexate , actinomycin d , and folinic acid ) with co ( vincristine and cyclophosphamide ) , has resulted in an overall survival of 84 % ;
C0008497
choriocarcinoma
C0010934
actinomycin d